These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26227222)

  • 1. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
    Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
    Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
    Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
    Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
    Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
    Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
    J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
    Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
    Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of (5Z)-7-oxozeaenol on MDA-MB-231 breast cancer cells.
    Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ
    Anticancer Res; 2012 Jul; 32(7):2415-21. PubMed ID: 22753698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
    J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
    Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
    Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of (5Z)-7-oxozeaenol on the oxidative pathway of cancer cells.
    Acuña UM; Wittwer J; Ayers S; Pearce CJ; Oberlies NH; DE Blanco EJ
    Anticancer Res; 2012 Jul; 32(7):2665-71. PubMed ID: 22753724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
    Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
    Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
    Wang JH; Tseng CL; Lin FL; Chen J; Hsieh EH; Lama S; Chuang YF; Kumar S; Zhu L; McGuinness MB; Hernandez J; Tu L; Wang PY; Liu GS
    Theranostics; 2022; 12(2):657-674. PubMed ID: 34976206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
    Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
    Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM
    Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
    van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
    Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
    Ear T; Fortin CF; Simard FA; McDonald PP
    J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
    Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
    Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.
    Huang HL; Chiang CH; Hung WC; Hou MF
    Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.